Twenty-one monoclonal antibodies reactive with Junin virus structural proteins were produced and characterized. Using radioimmunoprecipitation and Western blot assays, 13 were found to react with the nucleoprotein, seven with the surface glycoprotein and one failed to react, but showed a fluorescent antibody staining pattern consistent with other glycoprotein-specific antibodies. In radioimmunoprecipitation assays, glycoprotein-specific monoclonal antibodies reacted not only with the 35K
INTRODUCTION
Junin virus is a member of the New World group or Tacaribe complex of arenaviruses, and it together with Machupo and Lassa viruses comprise the three arenaviruses known to produce haemorrhagic fever in humans. Junin virus is endemic in Argentina (Weissenbacher et al., 1983) and is the aetiological agent of Argentine haemorrhagic fever. As with other arenaviruses, the natural reservoirs for Junin virus are rodents, specifically Calomys musculinus and C. laucha. These rodents transmit the virus to rural inhabitants and agricultural workers through direct or indirect contact (Sabattini et al., 1977) .
Arenaviruses contain two virus-specific RNA segments, L and S, which encode all the structural proteins. The S RNA segment codes for the nucleocapsid (N) protein and usually two glycoproteins (G) via a glycoprotein precursor (GPC) protein. Arenaviruses use an ambisense coding strategy for the S segment where mRNAs are transcribed from negative and positive sense forms of the S RNA (Auperin et al., 1984; Bishop & Auperin, 1987) . The L RNA segment encodes the viral polymerase (L protein).
In arenavirus-infected cells the major viral protein is the N protein, with an Me range of approximately 60K to 88K. Infected cells also contain the nonstructural GPC, with an M r range of approximately 65K to 80K, and is post-translationally processed to form the virion structural glycoprotein. For Junin virus the processing of the GPC has been shown to be sensitive to the antibiotic tunicamycin and is essential for infectivity (Padula & de Martinez Segovia, 1984) . The virions of many arenaviruses contain two structural glycoproteins, G 1 and G2, but several New World arenaviruses, namely Tacaribe, Tamiami and possibly Machupo and Junin viruses, seem to contain only one major glycoprotein (De Mitri & de Martinez Segovia, 1985; Lukashevich & Lemeshko, 1985; Buchmeier & Parekh, 1987) .
Several investigators have used polyclonal and monoclonal antibodies (MAbs) to examine the antigenic relationship of Junin virus to other arenaviruses (Wulff et al., 1978; Howard et al., 1985) . To re-examine this relationship, we have produced and characterized a panel of antiJunin virus MAbs. These antibodies have been used to determine the antigenic relationship of Junin virus to other arenaviruses and to identify epitopes involved in the neutralization of Junin virus. Results of these studies are the subject of this paper.
METHODS
Viruses and cells. Junin virus strains and arenaviruses used in this study were derived from stocks maintained at the U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, or at the Centers for Disease Control, Atlanta, Georgia. Viruses were propagated in Vero E6 cells (ATCC CRL 1586) grown in Eagle's minimal essential medium (EMEM) as described elsewhere (Elliott et al., 1982) . The P3406 strain of Junin virus (McKee et al., 1985 (McKee et al., , 1987 was passaged twice in MRC-5 cells, once in FRhL cells and once in Vero E6 cells, and was then used in the preparation of antigen for the immunization of mice. The non-secreting mouse myeloma cell line SP2/0-Ag-14 (ATCC CRL 1581) was used in the hybridoma fusions and cultured in Opti-MEM (Gibco) supplemented with 4% heat-inactivated foetal bovine serum (FBS). Antibiotics, when used, were at a concentration of 100 units of penicillin G, 50 ~tg of streptomycin and 2 ~tg of amphotericin B per ml (1 × antibiotics).
Purification of Junin virus. Virus was purified from the tissue culture fluid (TCF) of Vero E6 cultures infected at an m.o.i, of approximately 0.01 and incubated for 5 days at 36 °C. Virus was purified by polyethylene glycol precipitation and ultracentrifugation through successive gradients of 30 % glyceroN40 % potassium tartrate and 20 to 70% sucrose, as described elsewhere (Regnery et al., 1980) . When radioactive labelling of viral proteins was performed, [3SS]methionine, [3H]leucine or [3H] glucosamine was added to cultures 24 h after infection at a concentration of I 0 to 20 ~tCi per ml. Virus preparations used to immunize mice for the production of hybridomas, were inactivated by ~, irradiation (2.5 MRad) on ice in a cobalt-60 ~ cell (Elliott et al., 1982) , and tested for safety by culturing on Vero E6 cells.
Immunization of animals. Purified virus and virus-infected BALB/c suckling mouse brain (SMB) were used to immunize 8-week-old female BALB/c mice. Mice were initially immunized by subcutaneous and intraperitoneal (i.p.) injection of a 1:1 emulsion of 20% (v/v) infected SMB (total brain homogenate in physiological saline, inactivated with ~, irradiation, as above) and Freund's complete adjuvant. Two weeks later and 4 weeks later, animals were inoculated i.p. with 0.5 ml of the 20% infected SMB without adjuvant. After 2 months, serum antibody titres were determined by an indirect fluorescent antibody (IFA) technique using Junin virus-infected E6 cells (strain P3406) as described elsewhere (Johnson et al., 1981) . Four days prior to fusion, selected animals having a 1:1280 to 2560 titre were boosted by intravenous injection of purified virus.
Production ofhybridomas. Spleen cells from the animals described above were isolated and mixed at a 2 : 1 ratio with SP2/0-Ag-14 cells and fused by slowly adding 1 ml of 35 % polyethylene glycol 4000 in Dulbecco's phosphatebuffered saline (PBS) containing 15% DMSO, for 1 to 2 min with gentle mixing. The cells were washed, resuspended in Opti-MEM containing 6% FBS, 1 × antibiotics and HAT medium to a concentration of 5 x 105 cells per ml, seeded into 24-well plates and incubated at 37 °C in 5 % CO2 with a relative humidity of 98 %. Once the large hybridoma colonies had developed (after about 2 weeks), TCFs from wells were screened for anti-Junin virus IgG antibodies by IFA. Cells from positive wells were subcultured and cloned by limiting dilution in Opti-MEM containing 4% FBS.
Production of ascitic fluids. Mouse ascitic fluid (MAF) was produced in adult BALB/c females that had been injected i.p. with 0.5 ml pristane (2,6,10,14-tetramethylpentadecane) at least 3 weeks before. Mice were injected i.p. with 1 × l0 s to 5 × 105 hybridoma cells, and MAF was collected from swollen animals, usually after 9 days. Cells and debris were removed by centrifugation, supernatant fluids pooled, divided into aliquots and stored at -20 °C.
lgG isotyping ofMAbs. ELISA was used to determine IgG subclasses of MAbs derived from hybridoma TCF. The ELISA procedure was essentially that described by Hendry & Mclntosh (1982) using affinity-purified rabbit anti-mouse IgG isotype immunoglobulins (Miles Laboratories) coupled to 96-well polyvinylchloride microtitre plates (Dynatech Laboratories). TCF was reacted with the anti-isotype antibodies, followed by goat anti-mouse IgG-horseradish peroxidase (Tago). Enzyme activity was detected by the addition of citrate-phosphate buffer (100 mM-Na2PO 4, 50 mM-citric acid pH 5.0) containing 0.03 % hydrogen peroxide and 0.05 % o-phenylenediamine hydrochloride. Absorbance at 492 nm was measured with an automatic ELISA reader (Dynatech Micro ELISA Auto Reader Model MR 580).
Titration ofMAFs. MAFs were titrated by IFA assays and ELISA. In the IFA assay, the endpoint was set as the highest dilution showing an easily discernible fluorescence. In the ELISA, a 96-well polyvinylchloride microtitre plate was coated with antigen by adding 50 ~tl of polyethylene glycol-precipitated Junin virus (X J45 strain) in PBS to each well and drying overnight at room temperature. Residual binding was blocked by preincubation with PBS containing 10% FBS for 1 h at room temperature. Wells were washed with PBS containing 0.04% Tween 20, (PBST) then dilutions of MAF in PBS were added and allowed to react for 1 h at 37 °C. Wells were then washed with PBST and 100~1 of affinity-purified, alkaline phosphatase-labelled, goat anti-mouse IgA + IgM + IgG (Kirkegaard and Perry) was added and reacted for 1 h at 37 °C. Wells were washed with PBST and developed using disodium o-nitrophenyl phosphate as substrate. After 30 min the absorbance values were measured in an automatic ELISA reader as described above. Titres were expressed as the reciprocal of the highest dilution that yielded a reading two standard deviations above that obtained with normal myeloma-derived (SP2/0-Ag-14) MAF.
Virus neutralization assay. MAb MAFs were assayed for plaque reduction neutralization using a constant virus inoculum and varying antibody dilutions. The test was peformed by mixing an equal volume of virus [2000 p.f.u./ml in PBS containing 0.75 ~ bovine serum albumin (fraction V) and 1 x antibiotics] with test antibody (diluted in PBS containing 20% fresh normal human serum and 1 × antibiotics). These mixtures were incubated at 36 °C for 30 min, then duplicate 0.1 ml samples were added to confluent lawns of Vero E6 cells. An 80~ reduction in the number of p.f.u, compared to normal human serum was deemed a positive neutralization titre.
Radioimmunoprecipitation (RIP) ofviralproteins. Confluent monolayers of E6 cells in 25 cm 2 flasks infected with
Junin virus at an m.o.i, of 0-1 were used for RIP assays. At 48 h post-infectionl cells were washed and then incubated for 1 h wth 3 ml of methionine-free EMEM (containing 2% dialysed FBS). The medium was removed, 0.4 ml of methionine-free EMEM containing 100 I-tCi of [35S]methionine was added and the flasks were incubated for 5 h. The radioactive medium was removed, the ceils were rinsed twice with cold TNE buffer (10 mM-Tris-HCl pH 7-6, 150 mM-NaCI, 3 mM-EDTA) and then 0-5 ml lysis buffer (1% w/v Nonidet P-40, 0-5% w/v sodium deoxycholate and 0.1% w/v SDS, in TNE buffer) was reacted with the cells for several min. The resulting cytoplasmic extract was reacted with antibodies in RIP assays. In some assays, extracts were clarified by ultracentrifugation to remove nucleocapsids prior to the addition of antibodies. Immunoprecipitation of viral proteins and separation by SDS-PAGE was performed as previously described (Sanchez & Kiley, 1987; Laemmli, 1970) .
Enzyme immunoassay of Western-blotted viral proteins.
Virion proteins separated by SDS-PAGE as described above were electrophoretically blotted onto nitrocellulose (Schleicher & Schuell) as described elsewhere (Towbin et al., 1979) . Reactions of MAbs and polyclonal sera were performed in Tris-saline-Tween 20 buffer (10 mM-Tris-HC1 pH 7.6, 150 mM-NaCI, 0.3% v/v Tween 20) containing 5% (w/v) Carnation dried milk. Horseradish peroxidase conjugated with goat anti-mouse or with goat anti-human serum was used as the second antibody, and the enzyme reaction was performed in citrate-phosphate buffer pH 5-0, containing 0.03~ H202 and 0-05% 3,3-diaminobenzidine.
RESULTS

Viral proteins
SDS-PAGE analysis of Junin virus proteins is presented in Fig. 1 
MAb production and characterization
From two fusions, 160 of 552 wells showed antibody that reacted with homologous antigen. Subcloning of these positive cells resulted in the isolation of 21 unique monoclonal hybridomas secreting an antibody which is reactive with the Junin virus antigen in 1FA assays. Of the 21 MAbs, 14 were of the IgG1 subclass, five were IgG2a, one was IgG2b and one was IgG3 (Table  1) . Initial screening by IFA identified two basic groups of MAbs based on reactivities with homologous acetone-fixed antigen. One group, exemplified by clone GB03-BE08 in Fig. 2 (a) , showed a diffuse cytoplasmic staining pattern, whereas another group, characterized by clones SA02-BG12 and NA05-AG12 in Fig. 2(b) and (c), showed a granular or speckled pattern. Reaction of MAbs in RIP and Western blot tests were specific for two viral structural proteins, N and G, and MAbs showing the diffuse pattern in IFA assays were shown to react specifically with the 35K glycoprotein, whereas those showing the speckled pattern reacted with virus nucleoprotein (Fig. 1) 
* D, diffuse IFA pattern; S, speckled IFA pattern. t WB, Western blot EIA; G denotes glycoprotein-specific reaction; GW, weak glycoprotein reaction; N, nucleoprotein specific reaction; N + , reactivity with N and 27K protein; the minus sign ( -) , no neutralization at a 1:20 dilution.
:~ Neutralization and ELISA titres are given as log~0 values of the highest dilution giving a positive reaction. II Minus sign ( -) denotes no heterologous reaction; plus sign (+), heterologous reaction. compared to 10 for the Western blot, possibl~ reflecting antigenic sites that are dependent on protein conformation. In RIP assays, all G-reactive MAbs bound to a 67K protein which is thought to be the GPC. and all N-reacting MAbs reacted with three bands clustered in the area of the G protein, presumed to be breakdown products ol" N. The 27K protein present in purified virion preparations may also be a breakdown product of N, because no MAb reacts solely with this protein. When RIP assays were performed with infected cell lysates from which nucleocapsids had been removed, N-reactive MAbs failed to immunoprecipitate the N protein and the three bands that are presumed to be breakdown products ofN. The 27K protein was still easily immunoprecipitable under these conditions (data not shown) and together with Western blot results show it to be derived from N. Of the eight G-reactive MAbs studied, six had the ability to neutralize Junin virus in vitro (Table 1 ) and are capable of neutralizing without complement (data not shown). As expected, the N-reactive MAbs failed to neutralize virus infectivity.
Cross-reactivi O' wtih other arenaciruses
All MAbs prepared against the P3406 strain of Junin virus also reacted with two other virulent strains (P3235 and P3790) as well as the attenuated X J44 and Candid No. 1 strains (Kenyon et al., 1986; McKee et al., 1987) 
DISCUSSION
Monoclonal or polyclonal antibodies produced in response to viral antigens can be used to examine structure-function relationships among viral proteins, to study serological relationships among viruses and to develop more specific diagnostic tools. Our studies of MAbs generated against Junin virus antigens have attempted to address questions concerning the nature of Junin virus and its relationship to other members of the arenavirus family.
The neutralization of Junin virus by G-specific MAbs confirms the previous study of Cresta et al. (1980) , in which neutralization activity was shown to be associated with the glycoprotein. The lack of cross-reactivity of these MAbs with other arenaviruses suggests that G contains at least two type-specific epitopes (neutralizing and non-neutralizing). By analogy to another arenavirus, Lassa virus, which contains two glycoproteins, the single Junin virus glycoprotein seems to behave more similarly to the G1 protein than to the G2. In the Lassa virus system, MAbs reactive with the G 1 protein are type-specific, but several MAbs to the Lassa virus G2 glycoprotein react with members of the Tacaribe complex as well as the lymphocytic choriomeningitis (LCM) complex (unpublished data). Additional evidence lies in the work of Buchmeier et al. (1981) , who observed that MAbs to the G1 of LCM virus had neutralizing capabilities comparable to polyclonal antisera, and that a single MAb to G2 neutralized poorly. If the G 1 protein of certain arenaviruses contains the major neutralizable receptor-binding site, one might then conclude that the single glycoprotein of Junin virus is Gl-like.
Our RIP studies with the Junin virus MAbs indicated that all anti-G MAbs also reacted with an intracellular precursor, GPC. Assuming that this precursor is cleaved in a manner similar to that seen with other arenavirus GPC protein we had hoped that some of the MAbs might react with a second GPC cleavage product. In early experiments, at least four structural glycoproteins were reported (de Martinez Segovia & De M itri, 1977; Cresta et al., 1980; Grau et al., 1981) (Lukashevich & Lemeshko, 1985) , but one cannot eliminate the possibility that in these viruses two glycoproteins comigrate during SDS-PAGE.
Our observation that N-reactive Junin virus MAbs also react with breakdown products in RIP and Western blot assays echoes similar reports for the N proteins of other arenaviruses (Buchmeier & Parekh, 1987; Harnish et aL, 1981 ; Clegg & Lloyd, 1983; Young et al., 1987) . The presence of a 24K to 28K protein in purified virion preparations of Junin virus and other arenaviruses may point to a similarity in the susceptibility of the N protein to cellular degradation. This small protein may be important in the biology of the infectious process, possibly through the nuclear involvement that has been described in Pichinde virus-infected Vero cells (Young et aL, 1987) . Whether this protein has a functional role or is merely an artefact has yet to be resolved. Questions regarding the molecular biology of the nucleoprotein, as well as the processing of the GPC, will be more easily addressed when the Junin S RNA is cloned, sequenced and expressed.
Our examination of the serological relationships of arenaviruses using these anti-Junin virus MAbs confirmed and extended the results of others using both polyclonal antibodies and MAbs to arenaviruses. Wulff et aL (1978) , using both rodent and human convalescent-phase sera in an IFA assay, demonstrated that most of the New World viruses cross-react with each other to some extent and that antisera prepared against Old World viruses did not react to any degree with Tacaribe complex viruses, and vice versa. These results are consistent with earlier studies using IFA (Rowe et al., 1970) and complement fixation (Casals et al., 1975) assays. The heterologous reactions observed with our anti-Junin virus MAbs are similar to, but more extensive than, those described previously in studies using both anti-Tacaribe and anti-Junin virus MAbs (Howard et al., 1985) . In that study, of the seven anti-Junin virus MAbs tested (presumed N-specific) all reacted with Machupo and Tacaribe virus antigens, and one also reacted with Pichinde virus. Our studies also show that the N protein of Junin virus is very closely related to the N proteins of Machupo and Tacaribe viruses and that it shares several antigenic determinants with Amapari and Latino viruses. Other evidence for the close relationship of Tacaribe and Junin viruses comes from animal experiments where it has been demonstrated in both guinea-pigs and non-human primates that prior infection with Tacaribe virus will protect animals from disease when they are subsequently challenged with a lethal strain of Junin virus (Coto et al., 1980; Weissenbacher et al., 1982) .
The N-reactive MAbs can be subgrouped according to their ability or inability to react with the 27K protein, as shown in Fig. 1 by the MAbs SA02-BG12 and NA05-AG12, respectively. Taken together with the cross-reaction and Western blot data, and assuming that these patterns represent real antigenic differences, then at least 11 epitopic sites on the N protein have been identified. The numbers of sites recognized by a given MAb may also indicate how extensively that site is conserved in the other Tacaribe complex viruses. The fact that the anti-N MAbs which exhibit the greatest cross-reactivity (IC06-BE10 and JB02-BF08) also react with the 27K protein, suggests that this region of N may contain sequences that are highly conserved in the Tacaribe complex.
In conclusion, we hope to use the panel of anti-Junin MAbs as diagnostic reagents and as tools in the characterization of the Junin viral proteins, particularly the neutralizing epitopes on the glycoprotein. The panel should also provide a means of identification and characterization of any new arenaviruses, either natural or induced, that are antigenically related to the Junin virus.
